Grantham, Mayo, Van Otterloo & Co (GMO)
EAR

Grantham, Mayo, Van Otterloo & Co (GMO)’s Eargo, Inc. Common Stock EAR Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio EAR Stock Details EAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-4,865
Closed -$55.9K – 789
2022
Q4 		$55.9K Hold
4,865
– – ﹤0.01% 702
2022
Q3 		$102K Sell
4,865
-6,120
-56% -$165K ﹤0.01% 699
2022
Q2 		$165K Buy
10,985
+7,785
+243% +$368K ﹤0.01% 722
2022
Q1 		$339K Buy
+3,200
New +$316K ﹤0.01% 635

Other funds holding EAR

PSC
Patient Square Capital Menlo Park, California $564M AUM 261.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s EAR Position: Q1 2023 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Eargo, Inc. Common Stock (EAR) in Q1 2023, closing a stake of 4,865 shares — an estimated $55.9K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in EAR in Q1 2022 and held it in 4 quarters. The position peaked at $339K in Q1 2022. 24 funds tracked by Wall St. Rank hold EAR as of Q1 2023.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Eargo, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 4,865 Eargo, Inc. Common Stock shares in Q1 2023, an estimated $55.9K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Eargo, Inc. Common Stock in Q1 2022 and held it in 4 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Eargo, Inc. Common Stock position peaked at $339K in Q1 2022.
  • 24 funds tracked by Wall St. Rank held Eargo, Inc. Common Stock as of Q1 2023.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2023, filed 12 May 2023.